219 related articles for article (PubMed ID: 32049976)
21. CD30
Sauder MB; O'Malley JT; LeBoeuf NR
Hematol Oncol Clin North Am; 2017 Apr; 31(2):317-334. PubMed ID: 28340881
[TBL] [Abstract][Full Text] [Related]
22. Primary cutaneous CD30(+) lymphoproliferative disorders.
Wieser I; Tetzlaff MT; Torres Cabala CA; Duvic M
J Dtsch Dermatol Ges; 2016 Aug; 14(8):767-82. PubMed ID: 27509411
[TBL] [Abstract][Full Text] [Related]
23. Atopy, IgE and eosinophilic cationic protein concentration, specific IgE positivity, eosinophil count in cutaneous T Cell lymphoma.
Kural YB; Su O; Onsun N; Uras AR
Int J Dermatol; 2010 Apr; 49(4):390-5. PubMed ID: 20465692
[TBL] [Abstract][Full Text] [Related]
24. [Lymphomatoid papulosis: clinical and pathological findings in 18 patients].
Fernández-Guarino M; Carrillo-Gijón R; Jaén-Olasolo P
Actas Dermosifiliogr; 2012 Jun; 103(5):388-93. PubMed ID: 22261676
[TBL] [Abstract][Full Text] [Related]
25. CD30+ lymphoproliferative disorder: primary cutaneous anaplastic large cell lymphoma followed by lymphomatoid papulosis.
Aoki M; Niimi Y; Takezaki S; Azuma A; Seike M; Kawana S
Br J Dermatol; 2001 Jul; 145(1):123-6. PubMed ID: 11453920
[TBL] [Abstract][Full Text] [Related]
26. Pityriasis lichenoides et varioliformis acuta with numerous CD30(+) cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases.
Kempf W; Kazakov DV; Palmedo G; Fraitag S; Schaerer L; Kutzner H
Am J Surg Pathol; 2012 Jul; 36(7):1021-9. PubMed ID: 22472952
[TBL] [Abstract][Full Text] [Related]
27. Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders.
De Souza A; Tinguely M; Pfaltz M; Burghart DR; Kempf W
J Cutan Pathol; 2014 Dec; 41(12):901-6. PubMed ID: 25353265
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
Benner MF; Jansen PM; Meijer CJ; Willemze R
Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
[TBL] [Abstract][Full Text] [Related]
29. Mycosis Fungoides and Its Relationship to Atopy, Serum Total IgE, and Eosinophil Counts.
Vonderheid EC; Hamilton RG; Kadin ME
Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):279-288.e7. PubMed ID: 33342729
[TBL] [Abstract][Full Text] [Related]
30. Presence of IgE antibodies to bacterial superantigens and increased IL-13-producing T cells in myelitic patients with atopic diathesis.
Ochi H; Osoegawa M; Murai H; Minohara M; Taniwaki T; Kira J
Int Arch Allergy Immunol; 2004 May; 134(1):41-8. PubMed ID: 15051939
[TBL] [Abstract][Full Text] [Related]
31. Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders.
Vonderheid EC; Sajjadian A; Kadin ME
J Am Acad Dermatol; 1996 Mar; 34(3):470-81. PubMed ID: 8609262
[TBL] [Abstract][Full Text] [Related]
32. Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: successful treatment with recombinant interferon-gamma.
Yagi H; Tokura Y; Furukawa F; Takigawa M
J Invest Dermatol; 1996 Dec; 107(6):827-32. PubMed ID: 8941669
[TBL] [Abstract][Full Text] [Related]
33. Association of specific IgE to staphylococcal superantigens with the phenotype of chronic urticaria.
Ye YM; Hur GY; Park HJ; Kim SH; Kim HM; Park HS
J Korean Med Sci; 2008 Oct; 23(5):845-51. PubMed ID: 18955792
[TBL] [Abstract][Full Text] [Related]
34. Lymphomatoid papulosis in children: a retrospective cohort study of 35 cases.
Nijsten T; Curiel-Lewandrowski C; Kadin ME
Arch Dermatol; 2004 Mar; 140(3):306-12. PubMed ID: 15023774
[TBL] [Abstract][Full Text] [Related]
35. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis.
Nevala H; Karenko L; Vakeva L; Ranki A
Br J Dermatol; 2001 Dec; 145(6):928-37. PubMed ID: 11899146
[TBL] [Abstract][Full Text] [Related]
36. Pediatric oral Epstein-Barr virus associated self-remitting CD30+ lymphoproliferative disorder: A distinct entity.
Schwartz Z; Bowe RB; Coleman M; Magro CM
Ann Diagn Pathol; 2018 Dec; 37():57-61. PubMed ID: 30292067
[TBL] [Abstract][Full Text] [Related]
37. Primary cutaneous CD30+ lymphoproliferative disorder--a 10-year follow-up. A case report and differential diagnosis.
Szpor J; Dyduch G; Gałazka K; Bahyrycz J; Stój A; Tomaszewska R
Pol J Pathol; 2009; 60(1):43-8. PubMed ID: 19670703
[TBL] [Abstract][Full Text] [Related]
38. IgE-binding components of staphylococcal enterotoxins in patients with atopic dermatitis.
Nissen D; Pedersen LJ; Skov PS; Vejlsgaard GL; Poulsen LK; Jarløv JO; Karlsmark T; Nolte H
Ann Allergy Asthma Immunol; 1997 Nov; 79(5):403-8. PubMed ID: 9396971
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous CD30 positive lymphoproliferative disorders with coexistent epithelial neoplasms: Report of two cases.
Newland KM; McCormack CJ; Prince HM; Lade S
Australas J Dermatol; 2015 Nov; 56(4):e83-7. PubMed ID: 25330922
[TBL] [Abstract][Full Text] [Related]
40. Increased IgE-antibodies to Staphylococcus aureus enterotoxins in patients with COPD.
Rohde G; Gevaert P; Holtappels G; Borg I; Wiethege A; Arinir U; Schultze-Werninghaus G; Bachert C
Respir Med; 2004 Sep; 98(9):858-64. PubMed ID: 15338798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
